Document is current
Any future updates will be listed below
-
Authors
Pferdehirt, Lara https://orcid.org/0000-0002-1968-3636
Damato, Anna R. https://orcid.org/0000-0003-3283-3958
Lenz, Kristin L.
Gonzalez-Aponte, Maria F. https://orcid.org/0000-0002-8139-312X
Palmer, Daniel
Meng, Qing-Jun https://orcid.org/0000-0002-9426-8336
Herzog, Erik D. https://orcid.org/0000-0001-7209-5174
Guilak, Farshid https://orcid.org/0000-0001-7380-0330
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (AG15768)
- License Information
-
More Information
Article History
Received: 7 December 2022
Accepted: 20 January 2025
First Online: 7 February 2025
Competing interests
: Farshid Guilak is an employee and shareholder in Cytex Therapeutics, Inc. Farshid Guilak and Lara Pferdehirt are co-inventors of US Patent Application No. 18/284,487 entitled “Compositions and Methods for Cell-Based Delivery Systems” (currently pending). relating to the development of chronogenetic gene circuits used in this study. Anna R. Damato, Kristin L. Lenz, Maria F. Gonzalez-Aponte, Daniel Palmer, Qing-Jun Meng, Erik D. Herzog declare no competing interests.
